We spoke with Gianmarco Orgnoni, COO of Vection Technologies (ASX:VR1) about the impact COVID-19 is having on the business and what opportunities are emerging for the company on the back of its AR and VR technologies.
Skip to content
Skip to sidebar
Skip to footer
Related Videos
View all →-
Clarity Pharmaceuticals · CU6 Clarity Pharmaceuticals (ASX:CU6) presents at our Meet the CEO event, 3 March 2022 March 10, 2022
